# A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush

> **NCT00000951** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 948 (—)

## Conditions studied

- Candidiasis, Oral
- HIV Infections

## Interventions

- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT00000951
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2002-05
- **Target enrollment:** 948 (—)
- **Last updated:** 2021-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000951, "A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00000951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*